GHK-Cu
Tracks
Subjective Outcome
16 compoundsin Regimen’s catalog are configured to track mood via Rate Today. Each one shows the dose range, listed benefits, and every outcome it’s set up to monitor. Tap through to plan a dose with the free reconstitution calculator.
Mood responds to multiple peptide and hormone classes. Testosterone replacement in hypogonadal men shows a modest but reproducible antidepressant effect: a 2019 JAMA Psychiatry meta-analysis of 27 trials reported a standardized mean difference of −0.21 in depression symptom scores versus placebo. The effect is strongest in men with both low testosterone and clinical depression.
Selank and semax are small synthetic peptides studied primarily in Russia for anxiolytic and nootropic effects. The clinical evidence is sparse outside that literature and they are not FDA-approved. Anecdotal reports describe mood elevation; rigorous Western RCTs are not available.
GLP-1s have a mixed mood signal. Most users report no change. A subset reports anhedonia or flat affect, possibly tied to the same dopaminergic suppression that quiets food noise. Trial-level data has not consistently shown a depression signal across STEP and SURMOUNT, but real-world surveillance is ongoing.
Anchor citation: Walther A et al.. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men. JAMA Psychiatry, 2019.
16 compounds
Tracks
Tracks
Tracks
Bremelanotide
A melanocortin receptor agonist that enhances sexual desire and arousal in both men and women by acting centrally via the nervous system.
Tracks
Human Chorionic Gonadotropin
Glycoprotein hormone produced during pregnancy. Mimics luteinizing hormone (LH), stimulating Leydig cells in the testes to produce testosterone and maintain testicular volume. Commonly co-administered with TRT to preserve fertility and prevent testicular atrophy, or used as a post-cycle/restart bridge.
Tracks
Testosterone Ester (TRT)
Testosterone replacement therapy using a long-acting ester for stable hormone levels.
Tracks
Tracks
Tracks
Tracks
Tracks
Thymic Immune-System Modulator
A 28-amino-acid synthetic copy of a naturally occurring thymic peptide. Acts as an immune-system modulator (not a growth-hormone or anabolic peptide) by influencing T-cell maturation and innate immunity. Approved abroad as Zadaxin in 35+ countries for chronic hepatitis B and as an adjuvant in oncology — not FDA-approved in the US for general use. Typically cycled 6–12 weeks.
Tracks
Intranasal Social-Bonding Neuropeptide
A nine-amino-acid neuropeptide explored in research as an intranasal spray for social cognition, anxiety, and bonding effects. This entry reflects research-protocol intranasal microdosing only — distinct from obstetric IV oxytocin used during labor.
Tracks
Pulsatile GnRH for HPG Axis Support
A synthetic decapeptide identical to native GnRH that triggers pituitary LH and FSH release, downstream stimulating endogenous testosterone and spermatogenesis. Used adjunctively in TRT to preserve testicular function and in hypogonadotropic hypogonadism via pulsatile dosing.
Tracks
Khavinson Pineal-Derived Tripeptide
A synthetic tripeptide (Glu-Asp-Arg) from Khavinson's bioregulator program at the St. Petersburg Institute of Bioregulation. Animal studies report reduced ROS in cerebellar granule and PC12 cells, plus improved cognitive outcomes in prenatal hyperhomocysteinemia and Alzheimer's mouse models.
Tracks
Angiotensin IV-Derived c-Met Activator
An orally bioavailable, blood-brain-barrier-penetrant hexanoyl-modified analog of angiotensin IV that potentiates the hepatocyte growth factor (HGF) / c-Met system. Preclinical work reports synaptogenesis at picomolar concentrations and reversal of scopolamine-induced cognitive deficits in rodents.
Tracks
28-aa Anti-Inflammatory Neuropeptide
A 28-amino-acid neuropeptide signaling through VPAC1/VPAC2 receptors. Established anti-inflammatory and immunomodulatory effects across innate and adaptive immunity. Used clinically off-label as an intranasal preparation in chronic inflammatory response syndrome (CIRS) protocols.
Tracks
Testosterone replacement in hypogonadal men has the strongest evidence — the 2019 JAMA Psychiatry meta-analysis found a small but statistically significant antidepressant effect. Peptides marketed for mood (selank, semax) lack Western RCT evidence. Anyone considering peptides as a treatment for clinical depression should work with a psychiatrist; peptides are not a substitute for evidence-based psychiatric care.
A subset of GLP-1 users report flattened affect, anhedonia, or low motivation. This has not been confirmed as a class effect in trial-level data, but real-world reports are common enough that the FDA is monitoring the signal. If mood changes appear after starting a GLP-1, it’s worth logging — Regimen’s Rate Today + Reactions Journal captures this directly.
The mood response to testosterone replacement is typically measurable by week 3–6 and continues to improve over 6 months. Trough-level dosing schedules (twice-weekly injections, daily topical) produce steadier mood than once-weekly schedules because of less hormonal variability.
Related reading
Best peptide tracker app in 2026
An honest multi-protocol comparison of Regimen, PeptIQ, Shotsy, MeAgain, and the GLP-1 calculator apps.
Other outcomes